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Introduction
Chromosome segregation during anaphase requires the attach-
ment of kinetochores to the mitotic spindle and removal of sister 
chromatid cohesion (Peters et al., 2008). In particular, cohesin 
must be cleaved by separase (Esp1 in yeast), which is kept in check 
by securin (Pds1 in yeast) until anaphase onset (Uhlmann, 2001). 
The ubiquitin ligase anaphase-promoting complex (APC) bound 
to its activator Cdc20 drives securin proteolysis and cohesin cleav-
age by separase at the metaphase-to-anaphase transition, thereby 
allowing sister chromatid separation (Nasmyth, 2002; Peters, 
2006). Separase also contributes to mitotic exit and cyclin B prote-
olysis by acting in the Cdc14 early anaphase release (FEAR) path-
way for nucleolar release and activation of the Cdc14 phosphatase. 
Indeed, Cdc14 is kept inactive in the nucleolus for most of the cell 
cycle as part of the regulator of nucleolar silencing and telophase 
exit (RENT) complex, which includes the Cdc14 inhibitor Net1/
Cfi1 and the silencing protein Sir2 (Stegmeier and Amon, 2004). 
Besides separase, FEAR involves the polo kinase Cdc5, the Slk19 
kinetochore protein, Spo12, and Bns1 (Stegmeier et al., 2002) and 
is negatively regulated by protein phosphatase 2A (Queralt et al., 
2006), the replication fork block protein Fob1 (Stegmeier et al., 
2004), and Tof2 (Waples et al., 2009). By promoting a first wave 
of partial Cdc14 release from the nucleolus in early anaphase, 
FEAR allows activation of the mitotic exit network (MEN), which 
leads to complete Cdc14 release and activation, thereby triggering 
cyclin B proteolysis and mitotic exit (Visintin et al., 1998).
The spindle assembly checkpoint (SAC) is a ubiquitous 
safety device ensuring the fidelity of mitotic chromosome segrega-
tion. During the process of microtubule capture by kinetochores in 
U
pon prolonged activation of the spindle assembly 
checkpoint, cells escape from mitosis through a 
mechanism called adaptation or mitotic slippage, 
which is thought to underlie the resistance of cancer cells 
to antimitotic drugs. We show that, in budding yeast, this 
mechanism depends on known essential and nonessential 
regulators of mitotic exit, such as the Cdc14 early ana-
phase release (FEAR) pathway for the release of the 
Cdc14 phosphatase from the nucleolus in early anaphase. 
Moreover, the RSC (remodel the structure of chromatin) 
chromatin-remodeling  complex  bound  to  its  accessory 
subunit Rsc2 is involved in this process as a novel compo-
nent of the FEAR pathway. We show that Rsc2 interacts 
physically with the polo kinase Cdc5 and is required for 
timely phosphorylation of the Cdc14 inhibitor Net1, which 
is important to free Cdc14 in the active form. Our data 
suggest that fine-tuning regulators of mitotic exit have im-
portant functions during mitotic progression in cells treated 
with microtubule poisons and might be promising targets 
for cancer treatment.
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GAL1-MAD2 cells remained arrested for 4–5 h and then   
started to escape mitosis and enter in the next cycle, forming 
microcolonies of four or more cells on galactose-containing 
plates 6–8 h after release from G1 (Fig. 1 B) and eventually gen-
erating visible colonies (Fig. S1 B). Thus, Mad2-overproducing 
cells undergo mitotic slippage.
Characterization of SAC adaptation  
in yeast
In vertebrate cells, adaptation to the SAC takes place with SAC 
components  still  bound  to  kinetochores  and  is  accompanied   
by cyclin B proteolysis (Brito and Rieder, 2006). As shown in 
Fig. 2 A, yeast GAL1-MAD2 cells slipped out of mitosis and 
started reaccumulating in G1 7 h after release from G1 in the 
presence of galactose, with concomitant decrease of securin 
(Pds1) and cyclin B (Clb2) levels, whereas Mad2 levels remained 
constantly high. A similar independent experiment showed that 
GAL1-MAD2 cells carrying the tetracycline operator/repressor 
(tetO/tetR)–GFP system to monitor sister chromatid separation 
(Michaelis et al., 1997) also started separating sister chroma-
tids around the same time (Fig. 2 B). We then analyzed mitotic   
slippage in other conditions that engage the SAC by releas-
ing G1-arrested wild-type cells carrying the aforementioned   
tetO/tetR-GFP system in the presence of the microtubule- 
depolymerizing drugs nocodazole or benomyl. Bipolar spindles   
did not assemble in either condition, although a fraction of   
benomyl-treated cells displayed cytoplasmic microtubules 4 and   
6 h after release (see next paragraph). In spite of the complete 
absence of spindles, both nocodazole- and benomyl-treated 
cells underwent Pds1 and Clb2 degradation, separated sister 
chromatids, and slipped out of mitosis, although cells seemed 
to adapt faster in benomyl than in nocodazole (Fig. 2 C).   
In fact, benomyl-treated cells underwent almost complete Pds1 
and Clb2 degradation, which resulted in cell division and reac-
cumulation of unbudded cells within 10 h after release. At the 
same time, a considerable fraction of nocodazole-treated cells 
was still arrested as large-budded cells with relatively high levels 
of Clb2 (Fig. 2 C).
To assess if adaptation in yeast correlates with silencing 
of SAC signaling, we monitored the levels of Mad1–Bub3 inter-
action, which takes place only in the presence of unattached   
kinetochores (Brady and Hardwick, 2000; Fraschini et al., 
2001b) and therefore is a good readout for SAC signaling.   
G1-arrested cells expressing HA-tagged Bub3 (Bub3-HA3) were 
released in the presence of benomyl or nocodazole, followed by 
monitoring cell cycle progression by FACS analysis and Mad1–
Bub3 interaction by coimmunoprecipitation. Again, 4 and 6 h 
after G1 release, a fraction of benomyl-treated cells (10 and 
50%, respectively) displayed cytoplasmic microtubules (Fig. 2 E), 
which, in some cases, could drive an abnormal chromosome 
segregation (not depicted), but no bipolar spindles were detect-
able. Mad1–Bub3 interaction was stable up to 8 h after the G1 
release in nocodazole-treated cells that were still arrested with 
2C DNA content, whereas it started decreasing in the presence 
of benomyl after 4 h and was undetectable by 8 h, when most 
cells had exited mitosis (Fig. 2 D). The total levels of Mad1, but 
not of Bub3, also decreased in benomyl during the course of the 
prophase and prometaphase, the SAC proteins Bub3, Mad2,   
and Mad3/BubR1 form the mitotic checkpoint complex (MCC), 
which inhibits the activity of Cdc20–APC, thereby preventing 
sister chromatid separation and mitotic exit until all chromosomes 
reach proper bipolar attachment to the mitotic spindle. Other 
SAC proteins, such as Mad1, Bub1, Mps1, and Ipl1/AuroraB, 
amplify the signal and regulate the rate of MCC formation 
(Musacchio and Salmon, 2007). Most SAC proteins accumu-
late at unattached kinetochores during prophase and prometa-
phase and generate from this location the stop anaphase signal 
leading to Cdc20–APC inhibition, possibly by accelerating the 
rate of MCC formation (Musacchio and Salmon, 2007).
Cells do not arrest indefinitely upon SAC activation, but 
they escape mitosis after a variable amount of time in the pres-
ence of unattached kinetochores. The process by which cells 
leak through the SAC-induced cell cycle arrest when the check-
point is not satisfied is called adaptation or mitotic slippage 
(Rieder and Maiato, 2004). This process is largely responsible 
for the failure to efficiently block tumor progression with chemo-
therapeutic compounds targeting the mitotic spindle, such as 
taxanes and vinca alkaloids. In mammalian cells, mitotic slip-
page depends on progressive degradation of cyclin B, with SAC 
proteins being retained at kinetochores (Brito and Rieder, 2006; 
Gascoigne and Taylor, 2008). In yeast, inhibitory phosphoryla-
tion of cyclin B/Cdks has been proposed to accelerate adapta-
tion to prolonged SAC activation (Minshull et al., 1996).
Here, we report a role for the budding yeast RSC (remodel 
the structure of chromatin) chromatin-remodeling complex in 
timely mitotic exit and adaptation to the SAC as a novel com-
ponent of the FEAR network. The Rsc2-bound form of RSC ap-
pears to influence the rate of mitotic slippage by facilitating the 
nucleolar release of Cdc14, which then brings about cyclin B   
proteolysis and mitotic exit. Furthermore, our data suggest that 
Rsc2 regulates the FEAR function of the polo kinase Cdc5 in 
conditions that activate the SAC, but independently of SAC 
components, and provide a link between chromatin structure and 
the regulation of mitotic exit.
Results
MAD2 overexpression as a tool to study 
adaptation to the SAC
To study adaptation to the SAC, we set up conditions that lead 
to SAC hyperactivation without perturbing kinetochore attach-
ment to the mitotic spindle. We cloned MAD2 behind the strong 
galactose-inducible GAL1 promoter (GAL1-MAD2) and inte-
grated this construct in multiple copies in the yeast genome. 
We estimated that the levels of overexpressed Mad2 after 2 h 
in galactose are 20-fold higher than those of endogenous Mad2 
(unpublished data). GAL1-MAD2 cells released from G1 in the 
presence of galactose arrested transiently as large-budded cells 
with undivided nuclei, metaphase spindles, and high levels of 
nuclear Pds1 (Fig. 1 A). This metaphase arrest was caused by 
SAC hyperactivation as it was bypassed by MAD1 and MAD3 
deletions (not depicted), by PDS1 deletion (Fig. S1 C), and by 
expression of the dominant CDC20-107 allele (Fig. S1, A and B), 
which is refractory to SAC inhibition (Hwang et al., 1998).983 Cdc14 regulation by the RSC complex • Rossio et al.
Figure 1.  MAD2 overexpression induces a transient metaphase arrest. (A) Wild-type (wt; ySP4806) and GAL1-MAD2 (ySP8526) cells were grown in 
YEPR, arrested in G1 with -factor, and then released in YEPRG medium (t = 0). Samples were collected at the indicated times for FACS analysis of DNA 
contents and kinetics of budding, nuclear division, mitotic spindle formation/elongation, and Pds1 nuclear accumulation. Micrographs show examples of 
nuclear and microtubule staining (t = 150 min after release; bar, 5 µm). (B) Wild-type (W303) and GAL1-MAD2 (ySP6170) cells were grown in YEPR,   
arrested in G1 with -factor (unbudded cells), and spotted on YEPRG plates (t = 0). At the indicated times, 200 cells for each strain were scored to deter-
mine the frequency of single cells and of microcolonies of two, four, or more than four cells.JCB • VOLUME 191 • NUMBER 5 • 2010   984
Figure 2.  Mitotic slippage upon prolonged treatment with microtubule destabilizers correlates with degradation of APC substrates and dissociation be-
tween Mad1 and Bub3. (A) -factor–arrested GAL1-MAD2 (ySP8599) cells were released in YEPRG at 30°C (t = 0). -factor was readded at 3 µg/ml after 
2 h. Samples were collected at the indicated times for Western blot analysis of Pds1-myc18, Clb2, Mad2, and Swi6 (loading control). Cyc, cycling cells.   
(B) G1-arrested GAL1-MAD2 cells carrying the tetO/tetR-GFP markers to score sister chromatid separation (ySP6699; Michaelis et al., 1997) were released 
in YEPRG at t = 0. (C) -factor–arrested wild-type cells (ySP8534) were released in the presence of nocodazole or benomyl at t = 0. -factor was readded 
at 3 µg/ml after 2 h, and samples were collected at the indicated times for Western blot analysis (top) of Pds1-myc18, Clb2, and Cdc11 (loading control), 985 Cdc14 regulation by the RSC complex • Rossio et al.
cannot undergo Tyr19 inhibitory phosphorylation, or nondegrad-
able Clb2. In contrast, deletion of the cyclin B/Cdk inhibitor Sic1 
(Mendenhall, 1993; Schwob et al., 1994) had no effect.
We then asked whether SAC adaptation depends on cell 
cycle regulators that modulate mitotic exit and proteolysis of 
mitotic cyclins. Indeed, CDC20 repression from the MET3 
promoter markedly prolonged the metaphase arrest of GAL1-
MAD2 cells (Fig. 3 C), suggesting that high levels of Mad2 are 
not sufficient to maintain Cdc20–APC inhibition for a long time.   
Inactivation of the polo kinase Cdc5 through a MET3-CDC5 
fusion yielded similar results (Fig. 3 C).
Adaptation to the SAC upon MAD2 overexpression might 
also be influenced by advancing or delaying activation of the 
experiment but not as dramatically as in the Bub3 immuno-
precipitates. Therefore, adaptation to the SAC in yeast is accompa-
nied by silencing of checkpoint signaling.
Adaptation to the SAC requires cyclin B 
degradation, Cdc20, the polo kinase Cdc5, 
and Cdc14 nucleolar release
As SAC adaptation involves Clb2 proteolysis, we asked whether 
cyclin degradation, Cdk inhibitory phosphorylation, and/or Cdk 
inhibitors were required for mitotic slippage upon MAD2 over-
expression. As shown in Fig. 3 (A and B), microcolony formation 
of GAL1-MAD2 cells on galactose plates was effectively de-
layed by expression of either the Cdk1 variant Cdc28-F19, which   
as well as to monitor kinetics of budding, bipolar spindle formation, and sister chromatid separation (bottom graphs). (D and E). Cells expressing Bub3-
HA3 (ySP8709) were treated as in C. At the indicated times, interaction between Bub3-HA3 and Mad1 was assessed by coimmunoprecipitation using 
anti-HA antibodies followed by Western blotting with anti-Mad1 and anti-HA antibodies. At the same times, DNA contents were measured by FACS analysis   
(D, histograms) and for tubulin staining by immunofluorescence (E). MTs, microtubules. WCE, whole cell extract. Bar, 5 µm.
 
Figure 3.  SAC adaptation requires mitotic exit regulators. (A) GAL1-MAD2 (ySP6170), GAL1-MAD2 sic1 (ySP8706), and GAL1-MAD2 CDC28-F19 
(ySP8704) cells were grown in YEPR, arrested in G1 with -factor (unbudded cells), and spotted on YEPRG plates (t = 0) at 30°C. 200 cells were scored 
at each time point for microcolony formation. (B) Cycling cultures of GAL1-MAD2 (ySP3344) and GAL1-MAD2 GAL1-CLB2DB (ySP8710) cells grown 
in YEPR were spotted on YEPRG plates (t = 0) at 30°C to follow microcolony formation. A fraction of GAL1-MAD2 GAL1-CLB2DB cells remained unbud-
ded because Clb2DB inhibits budding (Surana et al., 1993). (C) GAL1-MAD2 (ySP6170), GAL1-MAD2 MET3-CDC20 (ySP8138), and GAL1-MAD2 
MET3-CDC5 (ySP8226) cells were grown in raffinose-containing medium lacking methionine, arrested in G1 with -factor (unbudded cells), and spotted 
on YEPRG supplemented with 2 mM methionine (t = 0) to follow microcolony formation. (D) GAL1-MAD2 (ySP6170), GAL1-MAD2 bub2 (ySP7677), and 
GAL1-MAD2 NET1-6Cdk (ySP7958) cells were treated as in A.JCB • VOLUME 191 • NUMBER 5 • 2010   986
this phenotype carried the transposon insertion 3 to the RSC2 
gene, encoding an accessory subunit of the chromatin-remodeling   
complex RSC (Cairns et al., 1999). Indeed, the Rsc2-containing   
RSC complex seemed a good candidate for adaptation to the   
SAC because it had been previously implicated in chromosome 
segregation, mitotic progression, and regulation of sister chro-
matid separation (Hsu et al., 2003; Baetz et al., 2004; Huang and   
Laurent, 2004). Moreover, RSC2 deletion was shown to have 
synthetic effects with mutations altering kinetochore compo-
nents or cohesin (Baetz et al., 2004).
The latter observations were extended by analyzing the 
effects of RSC2 deletion in a set of mutants in kinetochore   
components (Dam1 and Cep3) or microtubule-binding proteins 
(Stu2 and Cin8; Fig. S2 A). Besides confirming genetic inter-
actions previously reported by others, RSC2 deletion caused hyper-
sensitivity to benomyl and decreased the maximal permissive 
temperature of the kinetochore mutants dam1-11, cep3-10, and 
stu2-10, as well as that of cin8 cells lacking the BimC family 
kinesin Cin8, which has a major role in spindle assembly (Hoyt 
et al., 1992). Because the aforementioned mutations and beno-
myl treatment engage the SAC, the deleterious effects of RSC2 
deletion in these conditions might be caused by prolonged   
Cdc14 phosphatase that is necessary for mitotic exit. We thus 
forced unscheduled activation of the MEN and subsequent 
Cdc14 nucleolar release by eliminating the MEN inhibitor Bub2 
(Piatti et al., 2006). Conversely, we delayed Cdc14 activation by 
expression of a nonphosphorylatable Net1 variant (Net1-6Cdks) 
that does not allow the transient release of Cdc14 from the   
nucleolus in early anaphase (Azzam et al., 2004). Notably, 
BUB2 deletion accelerated microcolony formation of GAL1-
MAD2 cells on galactose plates, whereas NET1-6Cdk expres-
sion slowed it down (Fig. 3 D), suggesting that Cdc14 release 
from the nucleolus might be important for SAC adaptation.
The chromatin-remodeling RSC complex is 
involved in adaptation to the SAC
Because MAD2 overexpression provides a good experimental 
setup to study the molecular bases of SAC adaptation in the 
absence of spindle/kinetochore defects, we used transposon   
mutagenesis  of  GAL1-MAD2  cells  to  identify  factors  in-
volved in adaptation and/or in fine tuning of mitotic exit. To 
this end, we screened for clones that were hypersensitive to 
MAD2 overexpression and likely prolonged their cell cycle   
arrest under these conditions. We found that several clones with 
Figure 4.  The RSC complex is involved in SAC adaptation. (A) GAL1-MAD2 (ySP6170) and GAL1-MAD2 rsc2 (ySP6850) cells were grown in uninduced 
conditions (YEPR), arrested in G1 with -factor (unbudded cells), and spotted on YEPD (Glu) and YEPRG (Gal) plates (t = 0) at 30°C. 200 cells were scored 
at each time point for microcolony formation. (B) The same strains as in A were grown in uninduced conditions, arrested in G1 with -factor at 25°C, and 
released on YEPRG medium (t = 0) at 30°C. Samples were collected at the indicated times for Western blot analysis of Mad2 levels (arrow). Cyc, cycling 
cells. (C) The same strains as in A were treated as in B and plated at different times on YEPD plates to assess cell viability. Percentages represent mean 
values of three independent experiments. (D) GAL1-MAD2 (ySP6170) and GAL1-MAD2 GAL1-UBR1 CUP1-sth1
td (ySP7808) cells were grown in YEPR 
supplemented with 0.1 mM CuSO4, arrested in G1 with -factor (unbudded cells), and spotted on YEPRG plates (t = 0) at 37°C to follow microcolony 
formation. Data are representative of three independent repeats.987 Cdc14 regulation by the RSC complex • Rossio et al.
RSC2 deletion could prevent mitotic exit and rereplica-
tion of nocodazole-treated SAC mutants by either restoring 
Cdc20–APC inhibition or impinging on pathways controlling 
mitotic exit, such as the FEAR or MEN pathways for Cdc14 
nucleolar release. In fact, whereas Cdc20–APC is required 
for degradation of securin and a fraction of cyclin B, Cdc14 
triggers Cdh1/APC activation, which completes cyclin B deg-
radation and drives accumulation of the Cdk inhibitor Sic1 
(Visintin et al., 1998). To distinguish between these two pos-
sibilities, we first analyzed Pds1 and Clb2 degradation, as well 
as Sic1 accumulation, in wild-type, mad2, rsc2, and mad2 
rsc2 cells that were released from G1 in the presence of   
nocodazole. As shown in Fig. 5 C, Pds1 was degraded in both 
mad2 and mad2 rsc2 cells, whereas a fraction of Clb2 was 
stabilized and Sic1 did not accumulate in mad2 rsc2 cells, 
in contrast to mad2 cells. These results are consistent with 
the role of RSC in the regulation of mitotic exit and, in par-
ticular, of Cdc14 nucleolar release (see next paragraph), rather 
than in Cdc20–APC activation. Like RSC mutations, mutations   
affecting the FEAR pathway, such as esp1-1 (Fraschini et al., 
2001a), spo12 bns1, slk19 (Fig. S4 B), and NET1-6Cdk 
(not  depicted)  prevented  rereplication  of  nocodazole-treated 
mad2  cells.  In  addition,  simultaneous  deletion  of  SLK19, 
SPO12, and BNS1 retarded microcolony formation of GAL1-
MAD2 cells on galactose plates (Fig. S4 C). Similarly to FEAR 
mutations, RSC2 deletion only modestly delayed mitotic exit 
both in unperturbed conditions (Fig. 6 A) and during recovery 
from nocodazole arrest (Fig. 6 B), as judged by the kinetics of 
spindle disassembly relative to spindle elongation and nuclear 
division. Conversely, lack of Rsc2 delayed the onset of ana-
phase (i.e., spindle elongation and nuclear division) relative to 
bipolar spindle assembly (Fig. 6, A and B), which is consis-
tent with previous observations (Hsu et al., 2003; Baetz et al., 
2004). Thus, RSC
Rsc2 might regulate mitotic exit in a way simi-
lar to the FEAR pathway in conditions of SAC hyperactivation 
or in the presence of kinetochore/microtubule defects.
Lack of Rsc2 impairs Cdc14 release 
from the nucleolus at the metaphase-to-
anaphase transition
The persistence of Clb2 and the lack of Sic1 accumulation in 
nocodazole-treated mad2 rsc2 cells, together with the simi-
lar effects caused by RSC and FEAR inactivation in SAC mu-
tants upon microtubule disruption, suggested that RSC
Rsc2 might   
be involved in the control of Cdc14 release from the nucleolus. 
We therefore analyzed Cdc14 nucleolar release in mad2, 
rsc2, and mad2 rsc2 cells released from G1 in the presence 
of nocodazole. Although mad2 cells transiently released 
Cdc14, all other strains retained it in the nucleolus (Fig. 7 A), 
suggesting that RSC
Rsc2 is required for Cdc14 release in these 
conditions. Strikingly, expression of the Cdc14
TAB6-1 dominant 
variant that associates loosely to its inhibitor Net1 (Shou et al., 
2001) restored the ability of nocodazole-treated mad2 rsc2 
cells to rereplicate DNA (Fig. 7 B), whereas it was not sufficient 
by itself to promote mitotic exit in these conditions (not de-
picted). These data support the notion that RSC
Rsc2 inactivation 
interferes with Cdc14 nucleolar release and activation, prompting 
SAC activation. Indeed, RSC2 deletion turned out to be lethal 
for GAL1-MAD2 cells in the presence of galactose (Fig. S2 B and 
Fig. 4 C). We then scored microcolony formation of GAL1-MAD2 
and GAL1-MAD2 rsc2 cells upon plating G1-synchronized 
cells on media containing either glucose (GAL1-MAD2 off) or 
galactose (GAL1-MAD2 on). Deletion of RSC2 slightly delayed 
cell cycle progression on glucose plates compared with other-
wise wild-type cells in the presence of galactose (Fig. 4 A). Strik-
ingly, the presence of galactose caused GAL1-MAD2 rsc2 
cells to remain arrested in mitosis as large-budded cells for a 
longer time than GAL1-MAD2 cells (Fig. 4 A), in spite of com-
parable levels of Mad2 (Fig. 4 B). This behavior paralleled with 
the dramatic lethal effect of GAL1-MAD2 overexpression in 
rsc2 cells (Fig. 4 C).
Deletion of RSC1, encoding an RSC subunit alternative to 
Rsc2 (Cairns et al., 1999), had no effect on the mitotic escape of 
GAL1-MAD2 cells on galactose plates (Fig. S3 A), suggesting 
that the Rsc2-containing form of RSC (RSC
Rsc2) is specifically 
implicated in this process. The lack of Rsc2 also prolonged the mi-
totic arrest of MPS1-overexpressing cells (Fig. S3 B), which tran-
siently hyperactivate the SAC and eventually adapt (Hardwick 
et al., 1996), and of benomyl-treated cells (Fig. S3 C).
We then asked whether Rsc2 has a role in SAC adaptation 
as part of the RSC complex or independently of it. This was not 
trivial because all core RSC subunits are essential and must be in-
activated by temperature-sensitive mutations, whereas the GAL1 
promoter required to overexpress MAD2 is very inefficient at high 
temperatures. Indeed, GAL1-MAD2 cells showed only a modest 
cell cycle arrest at 37°C, as almost 50% of the cells had escaped 
from the arrest and formed microcolonies of four or more cells on 
galactose within 4 h after plating (Fig. 4 D). However, RSC inacti-
vation by the temperature-sensitive degron allele of STH1 (sth1
td; 
Parnell et al., 2008), which encodes the RSC catalytic subunit, 
delayed adaptation of GAL1-MAD2 cells by 2 h, suggesting that 
the whole RSC complex is involved in this process.
RSC
Rsc2 inactivation prevents mitotic exit 
of SAC-deficient mutants in the presence 
of microtubule-depolymerizing drugs
As RSC inactivation might delay escape from mitosis by pro-
longing the SAC-dependent cell cycle arrest, we investigated 
its effects in SAC-deficient mutants treated with microtubule- 
depolymerizing drugs. To this end, wild-type, mad2, rsc2, 
and mad2 rsc2 cells were arrested in G1 by -factor and 
released in the presence of nocodazole. As expected, mad2 
cells rereplicated their DNA efficiently and accumulated DNA 
contents higher than 2C under these conditions, which instead 
caused the double mad2 rsc2 mutant to arrest in mitosis 
similarly to wild-type and rsc2 cells (Fig. 5 A). Deletion of   
RSC2 prevented mitotic exit also of nocodazole-treated mad1, 
mad3, bub1, bub3, cdc55, and CDC20-107 cells (un-
published data). Moreover, rereplication of mad2 cells upon 
microtubule disruption was inhibited also by Sth1 inactivation 
through the sth1
td allele (Fig. 5 B), whereas it was not affected 
by RSC1 deletion (Fig. S4 A). Altogether, these data suggest 
that RSC
Rsc2 is required for the unscheduled mitotic exit of SAC 
mutants in the presence of spindle defects.JCB • VOLUME 191 • NUMBER 5 • 2010   988
bns1 cells arrested in telophase and showed no sign of total 
Cdc14 release. Moreover, Cdc14 partial release was abolished 
in GAL1-BFA1 spo12 bns1 cells and severely compromised 
in GAL1-BFA1 rsc2 cells (Fig. 7 C). Thus, Rsc2 and presum-
ably the whole RSC
Rsc2 complex contribute to the early ana-
phase release of Cdc14 from the nucleolus.
Deletion of RSC2 has synthetic effects 
with mutations affecting the MEN
We analyzed the relationships between RSC and the FEAR or the 
MEN cascades by combining RSC2 deletion with FEAR or MEN 
mutations. Deletion of RSC2 caused little or no synthetic growth 
defects when combined with the FEAR mutations slk19, spo12 
bns1, and esp1-1 (unpublished data), suggesting that RSC
Rsc2 
works together with or in parallel to the FEAR pathway.
Inactivation of the FEAR pathway is known to be lethal for 
cells lacking the nonessential MEN activator Lte1 (Stegmeier 
et al., 2002). Similarly, RSC2 deletion was found to be lethal 
with LTE1 deletion (Ye et al., 2005). In fact, rsc2 lte1 cells 
us to directly compare the kinetics of Cdc14 release from the 
nucleolus in rsc2 cells versus wild type and the FEAR mutant 
spo12 bns1. To monitor only the partial Cdc14 release at the 
anaphase onset, we prevented MEN activation by overexpressing 
BFA1 from the GAL1 promoter (Li, 1999). Wild-type, GAL1-BFA1, 
GAL1-BFA1 rsc2, and GAL1-BFA1 spo12 bns1 cells were 
synchronized in G1 and released in galactose-containing me-
dium. We then followed partial and total Cdc14 release from   
the nucleolus during the cell cycle. As expected, wild-type cells 
started releasing Cdc14 after metaphase spindles had been   
assembled and concomitant to spindle elongation (Fig. 7 C). 
Nuclear division immediately followed, and Cdc14 was com-
pletely released into the nucleoplasm and cytosol before cyto-
kinesis. Consistent with MEN inhibition, GAL1-BFA1 cells 
arrested in telophase as large-budded cells with 2C DNA con-
tents, divided nuclei, and elongated spindles. As expected, 
Cdc14 total release was abolished in these cells, and only the 
partial release in anaphase could be observed (Fig. 7 C). Like 
GAL1-BFA1 cells, GAL1-BFA1 rsc2 and GAL1-BFA1 spo12 
Figure 5.  Lack of the RSC complex prevents mitotic exit of nocodazole-treated SAC-defective cells. (A) Cultures of wild-type (wt), mad2, rsc2, and 
mad2 rsc2 cells (ySP4806, ySP1084, ySP6997, and ySP7543) were grown in YEPD, arrested in G1 by -factor, and then released into medium con-
taining nocodazole (t = 0). At the indicated times, cell samples were withdrawn for FACS analysis of DNA contents. (B) Cultures of mad2 (ySP1070) and 
GAL1-UBR1 CUP1-sth1
td mad2::TRP1 (ySP7869) cells were grown in YEPR containing 0.1 mM CuSO4 and arrested in G1 with -factor at 27°C. 1 h after 
2% galactose addition, cells were released in nocodazole-containing YEPRG at 37°C (t = 0), followed by FACS analysis of DNA contents at the indicated 
times. (C) The same strains and procedure as in A were used, but 10 µg/ml -factor was readded to all cultures at t = 100 min after release (>90% of 
budded cells). At the indicated times, cells were collected for FACS analysis of DNA contents (not depicted) and for Western analysis of Pds1, Clb2, Sic1, 
and Swi6 (loading control). Cyc, cycling cells.989 Cdc14 regulation by the RSC complex • Rossio et al.
cells contained Cdc5-Flag3, which was instead absent in the 
immunoprecipitates from the untagged Rsc2 strain (Fig. 9 A).   
Rsc2 could also bind the polo-box domain (PBD) of Cdc5, 
which normally binds substrates previously primed by phos-
phorylation by another kinase (Elia et al., 2003a). Indeed, Rsc2-
HA3 bound to a recombinant GST-PBD fusion protein (Miller 
et al., 2009) but not to GST alone (Fig. 9 B). Surprisingly, this 
binding was not disrupted by mutating the critical W
517V
518L
530 
residues (Elia et al., 2003b) into FAA, suggesting that it might 
be independent of preliminary phosphorylation.
Because Rsc2 binds to Cdc5 and is required for timely re-
lease of Cdc14 from the nucleolus, we evaluated whether RSC2 
deletion affected Net1 phosphorylation, which depends on 
Cdc5 and is required to release Net1-Cdc14 association (Shou 
et al., 2002; Yoshida and Toh-e, 2002). As shown in Fig. 9 D, 
a slow-migrating band corresponding to phosphorylated Net1 
(Visintin et al., 2003; Queralt et al., 2006) appeared during ana-
phase in wild-type cells (80–90 min after release from G1 arrest;   
Fig. 9 C), whereas it was barely detectable in the absence of Rsc2, 
suggesting that the FEAR function of Cdc5 might require the 
RSC
Rsc2 complex.
RSC was previously involved in sister chromatid cohe-
sion (Baetz et al., 2004; Huang and Laurent, 2004), and Cdc5 
facilitates cohesin cleavage and sister chromatid separation   
besides promoting Cdc14 activation (Alexandru et al., 2001). 
We then asked whether Cdc5 distribution along chromosomes 
was altered in the absence of Rsc2 by studying Cdc5-Flag3 chro-
mosomal distribution by ChIP (chromatin immunoprecipitation)- 
on-chip on the whole genome of yeast cells arrested in mitosis. 
were, in most cases, inviable or extremely sick also in our ge-
netic background (Fig. 8 A), and this lethality could be rescued 
by BUB2 deletion (not depicted), suggesting that it was caused 
by constitutive trapping of Cdc14 in the nucleolus. RSC2 dele-
tion also caused sickness and lethality when combined with the 
temperature-sensitive alleles cdc5-2, affecting polo kinase, and 
cdc14-3, respectively (Fig. 8 A). In addition, it decreased the 
maximal permissive temperature of the tem1-3, cdc15-2, dbf2-2,   
and cdc14-1 MEN mutants (Fig. 8 B), supporting the notion that 
RSC
Rsc2 regulates Cdc14 release from the nucleolus. Accord-
ingly,  RSC2  overexpression  suppressed  cdc15-2  lethality  at 
32°C (Fig. 8 C). Thus, RSC
Rsc2 controls Cdc14 release from the 
nucleolus at the metaphase/anaphase transition independently 
of MEN and in concert with the FEAR pathway.
Rsc2 interacts with the polo kinase  
Cdc5 and contributes to timely  
Net1 phosphorylation
FEAR components have been recently found to interact with 
the polo kinase Cdc5 (Rahal and Amon, 2008), which has a key 
role in Cdc14 nucleolar release acting in both the FEAR and 
the MEN pathways (Stegmeier and Amon, 2004). The Xenopus 
laevis homologue of Rsc2, polybromo-1/BAF180, was found to 
interact with polo kinase (Yoo et al., 2004), and Rsc2 itself was 
predicted to be a likely binding partner of Cdc5 (Snead et al., 
2007). To investigate whether Rsc2 interacts with Cdc5, we ex-
pressed Flag-tagged Cdc5 (Cdc5-Flag3) in cells expressing either 
untagged  Rsc2  or  HA-tagged  Rsc2  (Rsc2-HA3).  Rsc2-HA3 
immunoprecipitates from both cycling and nocodazole-arrested 
Figure 6.  Cell cycle progression of rsc2 cells and their recovery from SAC activation. (A) Cultures of wild-type (wt; ySP4806) and rsc2 (ySP6997) cells 
were grown in YEPD, arrested in G1 by -factor, and then released in fresh medium (t = 0). At the indicated times, samples were analyzed as in Fig. 1 A.   
(B) The same strains as in A were grown in YEPD, arrested in mitosis by 5 µg/ml nocodazole treatment, and then released (t = 0) in 10 µg/ml YEPD con-
taining -factor, followed by the same analyses as in Fig. 1 A.JCB • VOLUME 191 • NUMBER 5 • 2010   990
level, drives cells out of mitosis (Brito and Rieder, 2006;   
Gascoigne and Taylor, 2008). We show here that, similar to ver-
tebrate cells, mitotic slippage in budding yeast, either in the pres-
ence of microtubule inhibitors or upon SAC hyperactivation in 
the absence of spindle damage, is accompanied by securin and 
cyclin B degradation and is delayed by expression of nondegrad-
able cyclin B. As in mammalian cells (Brito and Rieder, 2006; 
Gascoigne and Taylor, 2008), the timing of mitotic slippage is 
highly variable depending on the conditions, ranging from 4 
to 5 h in benomyl, 5 to 6 h upon MAD2 overexpression, and 8 to   
10 h in nocodazole. We also find that, as recently shown in mam-
malian cells (Lee et al., 2010), Cdc20 and other canonical regu-
lators of cyclin B proteolysis and mitotic exit, such as the polo 
kinase Cdc5, are involved in SAC adaptation. In addition, the 
unphosphorylatable Cdc28-F19 variant delays mitotic slippage 
upon Mad2 overexpression consistently with the older proposal 
that inhibitory phosphorylation of cyclin B/Cdks accelerates   
adaptation to prolonged SAC activation (Minshull et al., 1996).   
Cdc5 localized at centromeres and discrete sites along chromo-
some arms corresponding to cohesin-binding sites (see the left 
arm of chromosome VI as an example; Fig. 10, A and B), and it 
could be found also at recombinant DNA (rDNA; not depicted). 
RSC2 deletion did not affect Cdc5 chromosomal distribution at 
any locus (Fig. 10 A and not depicted), suggesting that Rsc2 
might regulate Cdc5 at levels other than its recruitment to spe-
cific chromosomal regions.
Discussion
Adaptation to the SAC depends on 
regulators of mitotic exit
Eukaryotic cells ultimately adapt to persistent SAC signaling 
and exit from mitosis, eventually leading to unbalanced chro-
mosome segregation or cell death (Rieder and Maiato, 2004).   
Mitotic exit under these conditions is linked to a progressive 
decline in cyclin B/Cdk activity that, after reaching a threshold   
Figure 7.  Rsc2 controls the early release of Cdc14 from nucleolus. (A) -factor–arrested wild-type (wt; W303), mad2 (ySP1070), rsc2 (ySP6858), 
and mad2 rsc2 (ySP7088) cells were released in medium containing nocodazole (t = 0). At the indicated times, cells were collected for FACS 
analysis of DNA contents (not depicted) and for detecting Cdc14 release by immunofluorescence. (B) Cultures of mad2 rsc2 (ySP7088) and mad2 
rsc2 CDC14
TAB6-1 (ySP7645) were treated as in A. At the indicated times after release (t = 0), cells were collected for FACS analysis of DNA contents.   
(C) Cultures of wild-type, GAL1-BFA1, GAL1-BFA1 rsc2, and GAL1-BFA1 spo12 bns1 (W303, ySP1283, ySP7764, and ySP7803) cells were grown in 
YEPR, arrested in G1, and then released in YEPRG (t = 0). Samples were collected at the indicated times for FACS analysis of DNA contents and to follow 
the kinetics of budding, nuclear division, mitotic spindle formation/elongation, and Cdc14 partial/total release.991 Cdc14 regulation by the RSC complex • Rossio et al.
relies on the inability of the SAC to inhibit all Cdc20–APC com-
plexes inside the cell (Brito and Rieder, 2006). Presumably, a 
fraction of Cdc20–APC remains active upon SAC activation and 
promotes cyclin B destruction until cyclin B/Cdk activity drops 
below a threshold level sufficient to drive cells out of mitosis.
Cells expressing Cdc28-F19 were previously shown to be de-
fective in Cdc20–APC activation (Rudner et al., 2000), thereby 
explaining their ability to retard adaptation to the SAC. All these 
data indicate that mitotic slippage requires conventional regula-
tors of mitotic exit and are consistent with the proposal that it 
Figure 8.  Functional interactions between RSC2 and MEN genes. (A) Ratio of found/expected segregants observed over expected numbers of viable 
spores with the indicated genotypes after dissection of meiotic tetrads generated from diploid strains heterozygous for the rsc2 (ySP6859) and lte1 
(ySP3418) alleles, the cdc5-2 (ySP324) and rsc2 (ySP6859) alleles, or the rsc2 (ySP6859) and cdc14-3 (ySP284) alleles. *, very sick viable spores. 
(B) Serial dilutions of strains with the indicated genotypes were spotted on YEPD plates and incubated at the indicated temperatures. (C) Serial dilutions of 
strains with the indicated genotypes were spotted on YEPD (Glu, GAL1 promoter off) and YEPRG (Gal, GAL1 promoter on) plates and incubated for 2 d 
at 30°C and 32°C. wt, wild type.JCB • VOLUME 191 • NUMBER 5 • 2010   992
Figure 9.  Rsc2 interacts physically with Cdc5 and is required for timely Net1 and Cdc14 phosphorylation. (A) Wild type (wt; W303), CDC5-FLAG3 
(ySP7797), and RSC2-HA3 CDC5-FLAG3 (ySP7814) were grown exponentially or arrested in nocodazole for 3 h. Protein extracts were analyzed by 
Western blotting with anti-HA (Rsc2) or anti-Flag (Cdc5) antibodies either directly (total) or after Rsc2 immunoprecipitation with anti-HA antibodies (IPs). 
(B) A protein extract prepared from nocodazole-arrested cells expressing Rsc2-3HA (ySP7092) was incubated with glutathione-Sepharose beads carrying 
GST, GST-PBD, or mutated GST-PBD-FAA. Input and pull-down samples were analyzed by Western blotting with anti-HA or anti-GST antibodies. The bar 
with an asterisk denotes truncated forms of GST-PBD. (C and D) -factor–arrested wild-type (ySP8573) and rsc2 (ySP8596) cells expressing Net1-myc3 
were released in fresh medium at 25°C (t = 0). At the indicated times, cell samples were collected for FACS analysis of DNA contents (C, histograms), to 
measure the kinetics of budding, spindle formation/elongation, and nuclear division (C, graphs), and for Western blot analysis (D) of Net1-myc3, Clb2, 
and Pgk1 (loading control).993 Cdc14 regulation by the RSC complex • Rossio et al.
SAC signaling is a cause or a consequence of adaptation re-
mains to be established.
A role for the RSC complex in the early 
anaphase release of Cdc14 from the 
nucleolus and in mitotic exit regulation
We provide experimental evidence of a novel role for the   
chromatin-remodeling  complex  RSC  in  regulation  of  Cdc14 
nucleolar release and mitotic exit. Remarkably, histone post-
translational modifications have been recently implicated in the 
regulation of Cdc14 release from nucleolar chromatin in early 
anaphase (Hwang and Madhani, 2009), suggesting that multiple 
chromatin modifiers cooperate in this process.
The RSC complex regulates transcription mainly at PolII 
and PolIII promoters (Parnell et al., 2008) and has been implicated 
in several cell cycle processes, such as kinetochore function (Hsu 
et al., 2003) and sister chromatid cohesion (Baetz et al., 2004; 
Upon prolonged treatment with nocodazole, adaptation in 
vertebrate cells takes place with SAC proteins still at kineto-
chores, leading to the proposal that it occurs through SAC   
signaling override (Brito and Rieder, 2006). We show that adap-
tation to the SAC in budding yeast coincides with Mad1 dis-
sociation from Bub3, suggesting that the SAC is silenced. 
Microtubule-binding proteins, such as dynein and spindly, are 
involved in vertebrate SAC silencing through poleward trans-
port of SAC proteins along microtubules (Howell et al., 2001; 
Wojcik et al., 2001; Gassmann et al., 2010). Therefore, it is 
likely that spindle disruption by nocodazole impairs this mecha-
nism, thus accounting for the persistence of SAC proteins at   
unattached kinetochores during adaptation. In addition, Cdk   
activity is required to sustain the SAC (Li and Cai, 1997; 
Kitazono et al., 2003; Yamaguchi et al., 2003), and it drops dur-
ing adaptation, suggesting that SAC signaling is likely to de-
cline during mitotic slippage. In any case, whether silencing of 
Figure 10.  RSC2 deletion does not affect Cdc5 chromosomal distribution. Wild-type (wt; ySP7797) and rsc2 cells (ySP8200) expressing FLAG-tagged 
Cdc5 (A) and wild-type cells expressing PK-tagged Scc1 (B) were arrested in mitosis with benomyl and treated for ChIP-on-chip analysis. Enrichment of DNA 
fragments in the immunoprecipitate relative to a whole-genome DNA sample is shown along the first 160 kb (left arm and centromere) of chromosome VI. 
The y-axis scale is log2. Orange signals represent significant binding as previously described (Katou et al., 2003). The used statistical algorithm is identical 
to that for the GeneChip Operating Software (Affymetrix). The greenish signal indicates the centromere. Blue bars above and below the midline represent 
ORFs transcribed from left to right and opposite, respectively. A region around 140 kb masked by a gray box corresponds to Ty retrotransposon, which 
exists in multiple copies in the genome and was omitted from the analysis.JCB • VOLUME 191 • NUMBER 5 • 2010   994
Cdc14 nucleolar release by RSC might be exerted at levels differ-
ent from the rDNA. Several other possibilities can be envisioned: 
for example, RSC could have roles independent from its binding 
to chromatin, or it could locally regulate Cdc5 kinase activity 
and/or access to its substrates. Alternatively, because Cdc14 and 
Net1 bind to different sequences within the rDNA (Huang and 
Moazed, 2003; Stegmeier et al., 2004), and their binding is regu-
lated by Cdc5 (Shou et al., 2002), changes in chromatin structure 
might affect interactions within the RENT complex and/or make 
it more susceptible to Cdc5-dependent regulation. Interestingly, 
sister chromatid cohesion at the transcriptionally silent mating 
type loci requires both Sir2, which is also part of the RENT com-
plex (Shou et al., 1999), and RSC
Rsc2 (Chang et al., 2005), sug-
gesting that functional interactions between RSC and Sir2 may 
take place at other chromosomal locations.
Knowing the exact function of Cdc5 in the FEAR network 
and Cdc14 nucleolar release will certainly help addressing the 
role of RSC
Rsc2 in Cdc5 regulation. The FEAR function of Cdc5 
has been recently attributed primarily to Cdc5’s ability to stimu-
late degradation of Swe1, the Wee1-like Cdk inhibitory kinase 
(Liang et al., 2009). However, SWE1 deletion could not bypass 
the mitotic arrest of nocodazole-treated mad2 rsc2 cells (un-
published data), whereas the CDC14
TAB6-1 allele could do so, 
indicating that Cdc5 targets other substrates besides Swe1 to 
carry out its FEAR function. Interestingly, Cdc5 was recently 
shown to interact with Cdc14 (Snead et al., 2007; Rahal and 
Amon, 2008), suggesting that it might directly regulate its bind-
ing to Net1 and/or its phosphatase activity.
Budding yeast as a tool for the discovery 
of fine-tuning regulators of mitotic exit and 
candidate targets in cancer therapy
Recent data showed that cancer cells undergo two alternative 
and competing pathways after prolonged treatment to micro-
tubule toxins: either they die by apoptosis or slip out of mitosis 
(Gascoigne and Taylor, 2008). Both the apoptotic and slippage 
pathways have thresholds, and the fate of the cell is dictated 
by which threshold is breached first. Importantly, inhibiting the 
cell death pathway by caspase inactivation commits cells to slip 
out of mitosis, whereas interfering with cyclin B degradation 
and mitotic exit channels cells into the apoptotic pathway. Thus, 
discovering the factors that influence the rate of adaptation to 
microtubule toxins in different organisms is clearly a crucial 
issue in cancer research. For example, the efficacy of antimitotic 
drugs could be markedly increased by inhibiting factors involved 
in mitotic slippage, thus favoring cell death.
Our data indicate that the molecular bases for adaptation 
to chronic SAC activation are likely conserved in all eukaryotic 
cells, making budding yeast a good model system to identify 
factors influencing the rate of mitotic slippage. Indeed, MAD2-
overexpressing cells have proven to be a valuable tool to find 
novel factors involved in fine-tuning regulation of mitotic exit 
and  SAC  adaptation,  which  are  potential  targets  for  cancer 
treatment. Strikingly, mitotic exit has recently been proposed 
to be a better cancer therapeutic target than spindle assembly 
because Cdc20 inhibition efficiently kills cancer cells, prevent-
ing mitotic slippage and providing more time for apoptosis 
Huang and Laurent, 2004). However, transcriptional regulation of 
several classes of mitotic genes seems unaffected by RSC inacti-
vation (Cao et al., 1997), suggesting that this complex might   
have additional and perhaps more direct functions in cell cycle 
progression. Other chromatin regulators have been involved in cell 
cycle processes unrelated to their transcriptional function. For   
example,  chromatin-remodeling  proteins  were  also  found  at   
human centrosomes, where they regulate the recruitment of 
centrosomal proteins, microtubule organization, and cytokinesis   
(Sillibourne et al., 2007).
Budding yeast RSC associates with two alternative and 
closely related subunits, Rsc1 and Rsc2 (Cairns et al., 1999), 
which were previously found to be differentially involved in 
mitotic processes, such as sister chromatid cohesion and 2-µm 
plasmid partitioning (Wong et al., 2002; Baetz et al., 2004). 
However, Rsc1 and Rsc2 bind to the same chromosomal regions 
(Ng et al., 2002), raising the possibility that differences in their 
abundance might account for their unique properties. Our data 
indicate that RSC
Rsc2, and not RSC
Rsc1, is specifically implicated 
in Cdc14 activation and adaptation to the SAC. The involvement 
of RSC
Rsc2 in the control of mitotic exit is particularly apparent 
in conditions that activate the SAC, such as upon microtubule 
disruption or MAD2 overexpression. Indeed, RSC impairment 
through RSC2 deletion delays mitotic exit under these condi-
tions but not during the unperturbed cell cycle. In this respect, 
RSC mutants behave similarly to FEAR mutants, which show 
a marked mitotic exit defect only when the MEN is partially 
inactive (Stegmeier et al., 2002). This raises the interesting pos-
sibility that RSC is itself part of the FEAR or acts in a parallel 
pathway. Indeed, RSC2 deletion, like FEAR mutations (Stegmeier 
et al., 2002; Queralt and Uhlmann, 2008), impairs Net1 phos-
phorylation and prevents the partial nucleolar release of Cdc14 
in early anaphase. Furthermore, it is lethal for lte1 cells and 
causes synthetic lethality/sickness to several MEN mutants. 
How RSC
Rsc2 might regulate Cdc14 release from the nucleolus 
remains an open question, but our finding that Rsc2, like other 
FEAR components (Rahal and Amon, 2008), interacts physi-
cally with Cdc5 provides a possible mechanistic explanation. 
The Rsc2–Cdc5 interaction does not seem to require the critical 
residues in the PBD that are involved in phosphoepitope recog-
nition (Song et al., 2000; Elia et al., 2003b), suggesting that it 
might be independent of prior Rsc2 phosphorylation and follow 
unconventional rules. Interestingly, the homologue of Rsc2 in 
higher eukaryotes, Baf180, interacts with the polo-like kinase 
in X. laevis (Yoo et al., 2004).
How could RSC regulate the FEAR function of Cdc5?   
Because RSC was found at numerous PolII and PolIII promot-
ers (Ng et al., 2002) as well as at centromeres (Hsu et al., 2003), 
we wondered whether RSC might regulate Cdc5 recruitment to 
specific chromosomal regions. However, our ChIP-on-chip data 
rule out this possibility. We found that Cdc5 binds to the rDNA, 
where it might interact with the RENT complex and promote 
Cdc14 release, but this chromosomal location is also unaffected 
by RSC2 deletion (unpublished data). In addition, deletion of the 
whole rDNA region from chromosome XII did not rescue the 
ability of mad2 rsc2 cells to rereplicate DNA in the presence 
of nocodazole (unpublished data), suggesting that the control of 995 Cdc14 regulation by the RSC complex • Rossio et al.
Cdc11 (Santa Cruz Biotechnology, Inc.), Pgk1 (Invitrogen), Sic1, and 
Swi6.  Secondary  antibodies  were  obtained  from  GE  Healthcare,  and 
proteins were detected by an enhanced chemiluminescence system (ECL;   
GE Healthcare) according to the manufacturer.
Other techniques
Flow cytometric DNA quantitation and in situ immunofluorescence were 
performed  according  to  Fraschini  et  al.  (1999).  Nuclear  division  was 
scored  with  a  fluorescence  microscope  (Eclipse  E600;  Nikon)  on  cells 
stained with propidium iodide. To detect spindle formation and elongation, 
-tubulin immunostaining was performed with the YOL34 mAB (AbD Sero-
tec) followed by indirect immunofluorescence using rhodamine-conjugated 
anti–rat antibody (Thermo Fisher Scientific). Cdc14 immunostaining was 
performed with sc-12045 polyclonal antibodies (Santa Cruz Biotechnol-
ogy, Inc.) followed by indirect immunofluorescence using CY3-conjugated 
anti–goat antibody (GE Healthcare). Immunostaining of Pds1-myc18 was 
performed by incubation with the 9E10 mAb followed by indirect immuno-
fluorescence using CY3-conjugated anti–mouse antibody (GE Healthcare).   
ChIP-on-chip analysis was performed as previously described (Sutani et al.,   
2009). Digital images were acquired at room temperature on a fluorescence 
microscope equipped with a charge-coupled device camera (DC350F; Leica) 
with an oil 100× 1.3 NA Plan Fluor objective (Nikon) using FW4000 soft-
ware (Leica).
Online supplemental material
Fig. S1 shows that the mitotic arrest induced by MAD2 overexpression 
depends on SAC proteins and securin. Fig. S2 shows genetic interactions 
obtained combining RSC2 deletion with mutations in kinetochore compo-
nents or microtubule-binding proteins. Fig. S3 shows the effects of RSC2 
deletion  on  adaptation  to  the  SAC  upon  MAD2  or  MPS1  overexpres-
sion, as well as upon microtubule depolymerization by benomyl. Fig. S4 
shows that FEAR components, but not Rsc1, are required for mitotic exit 
of mad2 cells treated with nocodazole, as well as for adaptation upon 
MAD2 overexpression. Table S1 contains the list of yeast strains used in 
this study. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201007025/DC1.
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Materials and methods
Strains, media, and reagents
All yeast strains (Table S1) were derivatives of or were backcrossed at least 
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